Biolidics Ltd
SGX:8YY

Watchlist Manager
Biolidics Ltd Logo
Biolidics Ltd
SGX:8YY
Watchlist
Price: 0.037 SGD -5.13%
Market Cap: 64.1m SGD

Net Margin
Biolidics Ltd

-437.5%
Current
-660%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-437.5%
=
Net Income
-3.4m
/
Revenue
784k

Net Margin Across Competitors

No Stocks Found

Biolidics Ltd
Glance View

Market Cap
64.1m SGD
Industry
Health Care

Biolidics Ltd. operates as a medical technology company. The firm is primarily engaged in the research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics-related industrial design services and investment holdings. The company segments include cancer, infectious diseases and laboratory services. The cancer segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the cancer field. The infectious diseases segment involves the identifying and assessing collaboration partners, technology, products and services, product development, and the management of global distributorship networks and direct customers in the infectious diseases field. The laboratory services segment involves the business, operation and provision of laboratory services to customers.

8YY Intrinsic Value
0.001 SGD
Overvaluation 97%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-437.5%
=
Net Income
-3.4m
/
Revenue
784k
What is the Net Margin of Biolidics Ltd?

Based on Biolidics Ltd's most recent financial statements, the company has Net Margin of -437.5%.

Back to Top